We are live on
!
Find out more
EGI
EAM Global Investors Portfolio holdings
AUM
$47.1M
1-Year Est. Return
320.45%
This Fund
S&P 500
This Quarter
Est. Return
+30.7%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
–
AUM
$356M
AUM Growth
-$31.2M
(-8.1%)
Cap. Flow
-$69.9M
Cap. Flow
% of AUM
-19.65%
Top 10 Holdings %
Top 10 Hldgs %
18.36%
Holding
216
New
41
Increased
27
Reduced
12
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perion Network
PERI
|
+$5.36M |
| 2 |
Transocean
RIG
|
+$4.94M |
| 3 |
Wynn Resorts
WYNN
|
+$4.85M |
| 4 |
Lincoln Electric
LECO
|
+$4.8M |
| 5 |
ATI
ATI
|
+$4.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xenon Pharmaceuticals
XENE
|
+$5.77M |
| 2 |
ERF
Enerplus Corporation
ERF
|
+$4.93M |
| 3 |
Digi International
DGII
|
+$4.8M |
| 4 |
Extreme Networks
EXTR
|
+$4.71M |
| 5 |
MGP Ingredients
MGPI
|
+$4.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 30.49% |
| 2 | Technology | 24.32% |
| 3 | Consumer Discretionary | 15.04% |
| 4 | Healthcare | 15% |
| 5 | Financials | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
NBT Bancorp
NBTB
$2.72B
| – | – |
-32,446
| Closed | -$1.41M |
|
152
Northern Oil and Gas
NOG
$2.51B
| – | – |
-106,250
| Closed | -$3.27M |
|
153
NOV
NOV
$7.38B
| – | – |
-87,259
| Closed | -$1.82M |
|
154
Enpro
NPO
$6.98B
| – | – |
-15,161
| Closed | -$1.65M |
|
155
Nutanix
NTNX
$17.5B
| – | – |
-59,487
| Closed | -$1.55M |
|
|
NUVL
156
DELISTED
Nuvalent
NUVL
| – | – |
-41,001
| Closed | -$1.22M |
|
|
NVEE
157
DELISTED
NV5 Global
NVEE
| – | – |
-52,832
| Closed | -$1.75M |
|
158
Oceaneering
OII
$5.05B
| – | – |
-104,870
| Closed | -$1.83M |
|
159
Old Second Bancorp
OSBC
$1.28B
| – | – |
-88,940
| Closed | -$1.43M |
|
160
Par Pacific Holdings
PARR
$3.63B
| – | – |
-118,805
| Closed | -$2.76M |
|
161
Vaxcyte
PCVX
$8.72B
| – | – |
-41,018
| Closed | -$1.97M |
|
162
PDS Biotechnology
PDSB
$40.5M
| – | – |
-122,306
| Closed | -$1.61M |
|
163
Phreesia
PHR
$765M
| – | – |
-109,091
| Closed | -$3.53M |
|
164
Plexus
PLXS
$7.23B
| – | – |
-35,378
| Closed | -$3.64M |
|
165
Post Holdings
POST
$3.47B
| – | – |
-30,779
| Closed | -$2.78M |
|
166
Powell Industries
POWL
$7.57B
| – | – |
-132,546
| Closed | -$1.55M |
|
|
PR
167
Permian Resources
PR
$17.7B
| – | – |
-179,167
| Closed | -$1.68M |
|
168
Richardson Electronics
RELL
$296M
| – | – |
-83,854
| Closed | -$1.79M |
|
169
Replimune Group
REPL
$1.18B
| – | – |
-57,817
| Closed | -$1.57M |
|
170
Reinsurance Group of America
RGA
$15.9B
| – | – |
-14,481
| Closed | -$2.06M |
|
171
Rhythm Pharmaceuticals
RYTM
$7.92B
| – | – |
-62,623
| Closed | -$1.82M |
|
172
Shoals Technologies Group
SHLS
$1.44B
| – | – |
-53,431
| Closed | -$1.32M |
|
173
Syndax Pharmaceuticals
SNDX
$1.81B
| – | – |
-52,101
| Closed | -$1.33M |
|
174
StoneX
SNEX
$7.73B
| – | – |
-101,321
| Closed | -$1.91M |
|
175
ARS Pharmaceuticals
SPRY
$582M
| – | – |
-183,452
| Closed | -$1.56M |
|
Similar funds
IPHI
FCM
RRC
MCMC
CM
PFA
PCM
CCG
EAM Global Investors's Q1 2023 Portfolio in Review
As of Q1 2023, EAM Global Investors held 216 positions worth $356M, down 8.1% from $387M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
EAM Global Investors withdrew a net $69.9M in Q1 2023, closing 135 positions and reducing 12 holdings. Its most notable exit was Xenon Pharmaceuticals, an estimated $5.77M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Global Investors opened a new position in Perion Network worth $6.38M.
- EAM Global Investors's largest Q1 2023 buy was Perion Network: 161,132 shares worth $6.38M.
- EAM Global Investors added most to Iridium Communications in Q1 2023, an estimated $3.46M increase.
- EAM Global Investors's biggest Q1 2023 reduction was Viemed Healthcare, cutting an estimated $2.49M.
- EAM Global Investors fully exited Xenon Pharmaceuticals in Q1 2023, selling an estimated $5.77M.
- EAM Global Investors's ten largest holdings make up 18% of its $356M portfolio in Q1 2023.
- EAM Global Investors opened 41 new positions and closed 135 in Q1 2023.
- EAM Global Investors's portfolio value fell 8.1% quarter-over-quarter to $356M.
Based on EAM Global Investors's 13F filing for Q1 2023, filed 15 May 2023.